April 26, 2024

Pharmaceutical Giant Eli Lilly to Cap Monthly Out-of-Pocket Insulin Costs at $35

Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses. The company announced on Wednesday that it is moving forward with “price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or

FACT CHECK: Biden Claims He Capped Insulin Costs for Medicare Enrollees

CLAIM: President Joe Biden claimed during Tuesday’s State of the Union that the Democrats’ Inflation Reduction Act put a monthly cap srcf $35 on insulin costs for Medicare enrollees. VERDICT: Misleading. During Biden’s State of the Union address on Tuesday, he claimed,”Big Pharma has been unfairly charging people hundreds of dollars, four to five hundred dollars a month,”

Source: